Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02447406 |
|---|---|
| Brief Title: | Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment |
| First Submitted : | May 14, 2015 |
| First Submitted that Met QC Criteria : | May 15, 2015 |
| First Posted : | May 18, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 15, 2017 |
| Last Update Posted : | February 16, 2017 |